4//SEC Filing
ROSA-BJORKESON DAGMAR 4
Accession 0001104659-22-065901
CIK 0001270073other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:16 PM ET
Size
15.7 KB
Accession
0001104659-22-065901
Insider Transaction Report
Form 4
ROSA-BJORKESON DAGMAR
Director
Transactions
- Award
Option to Purchase Common Stock
2022-05-25+12,790→ 12,790 totalExercise: $16.82Exp: 2032-05-25→ Common Stock (12,790 underlying) - Award
Common Stock
2022-05-25+7,737→ 18,280 total
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2023 Annual Meeting of Stockholders.
- [F2]All of the options subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2023 Annual Meeting of Stockholders.
Issuer
INTERCEPT PHARMACEUTICALS, INC.
CIK 0001270073
Entity typeother
Related Parties
1- filerCIK 0001643934
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:16 PM ET
- Size
- 15.7 KB